Dara Capital US’s Medtronic MDT Stock Holding History

Dara Capital US’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	2,887 +737	+34%	+$59.5K	0.16%	74
2026 Q1	$186K	Hold	2,150	–	–	0.18%	80
2025 Q4	$207K	Buy	+2,150	New	+$209K	0.18%	81

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Dara Capital US's MDT Position: Q2 2026 in Review

Dara Capital US increased its Medtronic (MDT) stake by 34% in Q2 2026, buying an estimated $59.5K and bringing the position to 2,887 shares worth $226K. The position accounts for 0.16% of the portfolio, ranked #74.

Dara Capital US first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Dara Capital US held 2,887 shares of Medtronic worth $226K as of Q2 2026.
Dara Capital US bought 737 Medtronic shares in Q2 2026, an estimated $59.5K.
Medtronic made up 0.16% of Dara Capital US's portfolio in Q2 2026, its #74 holding.
Dara Capital US first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Dara Capital US's 13F filing for Q2 2026, filed 23 Jul 2026.